scholarly journals Increased Blood Pressure in α-Calcitonin Gene–Related Peptide/Calcitonin Gene Knockout Mice

Hypertension ◽  
2000 ◽  
Vol 35 (1) ◽  
pp. 470-475 ◽  
Author(s):  
Pandu R. R. Gangula ◽  
Huwai Zhao ◽  
Scott C. Supowit ◽  
Sunil J. Wimalawansa ◽  
Donald J. Dipette ◽  
...  
1994 ◽  
Vol 266 (1) ◽  
pp. H11-H16 ◽  
Author(s):  
K. W. Hong ◽  
K. M. Pyo ◽  
W. S. Lee ◽  
S. S. Yu ◽  
B. Y. Rhim

In anesthetized rats, we examined the possibility that calcitonin gene-related peptide (CGRP, a neuropeptide) released in response to transient hypotension may contribute to the reflex autoregulation of cerebral blood flow. Changes in pial arterial diameter (mean 33.0 +/- 1.1 microns) with changes in systemic arterial blood pressure (mean 101.9 +/- 2.7 mmHg) were observed directly through a closed cranial window. In capsaicin-treated rats (depletor of CGRP and substance P, 50 nmol capsaicin injected intracisternally 24 h before experiment), vasodilatation, which was evoked on transient hypotension, and vasoconstriction on reverse of hypotension were markedly attenuated or almost abolished. When changes in pial arterial diameter were plotted as a function of changes in blood pressure, the slopes of regression lines for vasodilatation and vasoconstriction were markedly reduced after capsaicin treatment. Similar reductions were evidenced under suffusion of CGRP antibody serum (1:1,000) and after CGRP receptor desensitization but not after substance P receptor desensitization. Pretreatment with glibenclamide, a K(+)-channel antagonist, also caused severe alterations in the autoregulatory vasomotor responses to hypotension and its reverse. Suffusion with mock cerebrospinal fluid, containing either CGRP or cromakalim, a K(+)-channel opener, dilated the pial artery in a concentration-dependent manner, and their effects were antagonized by glibenclamide. Substance P produced a vasodilatation, which was unaffected by glibenclamide.(ABSTRACT TRUNCATED AT 250 WORDS)


1988 ◽  
Vol 6 (4) ◽  
pp. S418-420 ◽  
Author(s):  
Akira Itabashi ◽  
Hideyuki Kashiwabara ◽  
Mayumi Shibuya ◽  
Keiko Tanaka ◽  
Hidehiko Masaoka ◽  
...  

1988 ◽  
Vol 74 (4) ◽  
pp. 413-418 ◽  
Author(s):  
C. W. Howden ◽  
Catherine Logue ◽  
Karen Gavin ◽  
Lizbeth Collie ◽  
P. C. Rubin

1. The effects of intravenous bolus doses of human calcitonin-gene-related peptide (hCGRP) were studied in ten healthy male volunteers. 2.5, 10 and 25 μg of hCGRP and placebo were administered to each subject in a randomized double-blind study. 2. hCGRP had no effect on systolic or diastolic blood pressure in the supine or standing position. 3. hCGRP increased supine and standing heart rate. Both the extent and duration of the tachycardia were dose related. 4. Plasma noradrenaline levels were transiently increased after 10 and 25 μg of hCGRP. 5. All subjects displayed marked facial flushing after the two higher doses of hCGRP. 6. We conclude that systemic administration of hCGRP produces tachycardia and stimulation of the sympathetic nervous system in the absence of any change in blood pressure.


2009 ◽  
Vol 27 (6) ◽  
pp. 1224-1232 ◽  
Author(s):  
Dai Li ◽  
Ben-Mei Chen ◽  
Jun Peng ◽  
Yi-Shuai Zhang ◽  
Xiao-Hui Li ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document